Asymmetric Aldol Reaction with Threonine Derivatives
1 H), 3.99 (d, J = 3.0 Hz, 1 H), 2.61–2.44 (m, 2 H), 2.35 (td, J =
12.9, 5.4 Hz, 1 H), 2.15–2.05 (m, 1 H), 1.85–1.75 (m, 1 H), 1.70–
1.50 (m, 3 H), 1.37–1.20 (m, 1 H) ppm.
excess: 96% (anti diastereomer) determined by HPLC (Daicel Chi-
ralpak AD-H column; iPrOH/hexane = 5:95; 1.0 mL/min, 20 °C, λ
= 254 nm) tR = 45.9 min (anti, major) and tR = 36.7 min (anti,
minor). 1H NMR (300 MHz, CDCl3): δ = 8.24–8.27 (m, 1 H, ArH),
7.84–7.89 (m, 1 H, ArH), 7.81 (d, J = 8.1 Hz, 1 H, ArH), 7.57 (d,
J = 6.3 Hz, 1 H, ArH), 7.45–7.53 (m, 3 H, ArH), 5.58 (dd, J = 8.7,
2.9 Hz, 1 H), 4.15 (d, J = 2.9 Hz, 1 H), 2.95–3.04 (m, 1 H), 2.49–
2.54 (m, 1 H), 2.35–2.45 (m, 1 H), 2.05–2.12 (m, 1 H), 1.61–1.74
(m, 2 H), 1.33–1.51 (m, 3 H) ppm.
(2S,10R)-2-[(2-Chlorophenyl)hydroxymethyl]cyclohexan-1-one (8):[7]
Yield 226.8 mg (0.95 mmol, 95%); anti/syn = 90:10, enantiomeric
excess: 98% (anti diastereomer) determined by HPLC (Daicel Chi-
ralpak OD-H column; iPrOH/hexane = 5:95; 1.0 mL/min, 20 °C, λ
= 221 nm) tR = 9.7 min (anti, major) and tR = 12.3 min (anti,
minor). 1H NMR (300 MHz, CDCl3): δ = 7.56 (dd, J = 7.6, 1.6 Hz,
1 H, ArH), 7.21–7.37 (m, 3 H, ArH), 5.35 (dd, J = 8.0, 3.6 Hz 1
H), 2.65–2.71 (m, 1 H), 3.88 (s, 1 H), 2.46–2.49 (m, 1 H), 2.31–2.39
(m, 1 H), 2.05–2.13 (m, 1 H), 1.53–1.84 (m, 5 H) ppm.
(2S,10R)-2-[(4-Bromophenyl)hydroxymethyl]cyclohexan-1-one (9):[7]
Yield 269.0 mg (0.95 mmol, 95%); anti/syn = 96:4, enantiomeric
excess: 98% (anti diastereomer) determined by HPLC (Daicel Chi-
ralpak AD-H column; iPrOH/hexane = 10:90; 0.5 mL/min, 20 °C,
λ = 220 nm) tR = 43.1 min (anti, major) and tR = 35.5 min (anti,
minor). 1H NMR (300 MHz, CDCl3): δ = 7.47 (d, J = 8.1 Hz, 2
H, ArH), 7.20 (d, J = 8.7 Hz, 2 H, ArH), 4.75 (dd, J = 8.7, 2.7 Hz,
1 H), 3.99 (d, J = 3.0 Hz, 1 H), 2.61–2.44 (m, 2 H), 2.35 (td, J =
12.9, 6.3 Hz, 1 H), 2.15–2.04 (m, 1 H), 1.85–1.75 (m, 1 H), 1.70–
1.50 (m, 3 H), 1.37–1.20 (m, 1 H) ppm.
(2S,10R)-2-[Hydroxy(phenyl)methyl]cyclohexan-1-one (15):[7] Yield
171.6 mg (0.84 mmol, 84%); anti/syn = 94:6, enantiomeric excess:
97% (anti diastereomer) determined by HPLC (Daicel Chiralpak
OD-H column; iPrOH/hexane = 10:90; 0.5 mL/min, 20 °C, λ =
220 nm) tR = 19.6 min (anti, major) and tR = 30.6 min (anti,
minor). 1H NMR (300 MHz, CDCl3): δ = 7.39–7.28 (m, 5 H, PhH),
4.80 (d, J = 9.0 Hz, 1 H), 4.00 (m, 1 H), 2.70–2.56 (m, 1 H), 2.55–
2.44 (m, 1 H), 2.34 (td, J = 12.3, 5.4 Hz, 1 H), 2.16–2.03 (m, 1 H),
1.87–1.73 (m, 1 H), 1.72–1.50 (m, 3 H), 1.40–1.22 (m, 1 H) ppm.
(2S,10R)-2-[Hydroxy(pyridin-4-yl)methyl]cyclohexan-1-one (16):[7]
Yield 197.0 mg (0.96 mmol, 96%); anti/syn = 81:19, enantiomeric
excess: 98% (anti diastereomer) determined by HPLC (Daicel Chi-
ralpak AD-H column; iPrOH/hexane = 10:90; 1.0 mL/min, 20 °C,
λ = 254 nm) tR = 27.5 min (anti, major) and tR = 25.0 min (anti,
minor). 1H NMR (300 MHz, CDCl3): δ = 8.53–8.55 (d, J = 6.0 Hz,
2 H), 7.25–7.28 (d, J = 6.0 Hz, 2 H), 4.80 (d, J = 8.4 Hz, 1 H),
4.29 (br., 1 H), 2.31–2.63 (m, 3 H), 2.07–2.12 (m, 1 H), 1.81–1.84
(m, 1 H), 1.61–1.1.71 (m, 4 H), 1.30–1.41 (m, 1 H) ppm.
(2S,10R)-2-[Hydroxy(4-methoxyphenyl)methyl]cyclohexan-1-one
(10):[7] Yield 208.5 mg (0.89 mmol, 89%); anti/syn = 93:7, enantio-
meric excess: 97% (anti diastereomer) determined by HPLC (Daicel
Chiralpak AD-H column; iPrOH/hexane = 10:90; 0.8 mL/min,
20 °C, λ = 221 nm) tR = 32.5 min (anti, major) and tR = 30.8 min
(anti, minor). 1H NMR (300 MHz, CDCl3): δ = 7.27 (d, J = 8.4 Hz,
2 H, ArH), 6.90 (d, J = 8.8 Hz, 2 H, ArH), 4.76 (d, J = 7.6 Hz, 1
H), 3.94 (s, 1 H), 3.83 (s, 3 H), 2.34–2.65 (m, 3 H), 2.08–2.14 (m,
1 H), 1.55–1.82 (m, 6 H), 1.20–1.40 (m, 2 H) ppm.
(2S,10R)-2-[Hydroxy(4-nitrophenyl)methyl]cyclopentan-1-one (17):[7]
Yield 232.9 mg (0.99 mmol, 99%); anti/syn = 56:44, enantiomeric
excess: 95% (anti diastereomer) determined by HPLC (Daicel Chi-
ralpak AD-H column; iPrOH/hexane = 5:95; 1.0 mL/min, 20 °C, λ
= 254 nm) tR = 58.4 min (anti, major) and tR = 55.4 min (anti,
minor); tR = 30.8 min (syn, major) and tR = 43.9 min (syn, minor).
1H NMR (300 MHz, CDCl3): δ = 8.21 (d, J = 8.7 Hz, 2 H, ArH),
7.54 (d, J = 9.0 Hz, 2 H, ArH), 4.85 (d, J = 9.2 Hz, 1 H), 4.76
(s, 1 H), 2.54–2.18 (m, 3 H), 2.08–1.95 (m, 1 H), 1.81–1.48 (m, 3
H) ppm.
(2S,10R)-2-[Hydroxy(3-methoxyphenyl)methyl]cyclohexan-1-one
(11):[7] Yield 201.5 mg (0.86 mmol, 86%); anti/syn = 93:7, enantio-
meric excess: 96% (anti diastereomer) determined by HPLC (Daicel
Chiralpak AD-H column; iPrOH/hexane = 10:90; 0.5 mL/min,
20 °C, λ = 221 nm) tR = 56.3 min (anti, major) and tR = 51.1 min
(anti, minor). 1H NMR (300 MHz, CDCl3): δ = 7.28–7.33 (m, 1 H,
ArH), 6.80–7.00 (m, 3 H, ArH), 4.80 (d, J = 8.7 Hz, 1 H), 3.85 (s,
3 H), 2.30–2.75 (m, 3 H), 2.00–2.15 (m, 1 H), 1.55–1.90 (m, 4 H),
1.20–1.40 (m, 1 H) ppm.
(2S,10R)-2-[Hydroxy(4-tolyl)methyl]cyclohexan-1-one (12):[7] Yield
181.2 mg (0.83 mmol, 83%); anti/syn = 99:1, enantiomeric excess:
Ͼ99% (anti diastereomer) determined by HPLC (Daicel Chiralpak
AD-H column; iPrOH/hexane = 10:90; 0.5 mL/min, 20 °C, λ =
221 nm) tR = 32.8 min (anti, major) and tR = 44.5 min (anti,
minor). 1H NMR (300 MHz, CDCl3): δ = 7.18 (dd, J = 17.1,
8.4 Hz, 4 H, ArH), 4.75 (dd, J = 9.0, 2.7 Hz, 1 H), 3.91 (d, J =
2.7 Hz, 1 H), 2.66–2.54 (m, 1 H), 2.51–2.43 (m, 1 H), 2.35 (td, J =
13.2, 6.0 Hz, 1 H), 2.34 (s, 3 H), 2.14–2.03 (m, 1 H), 1.82–1.72 (m,
1 H), 1.70–1.50 (m, 3 H), 1.38–1.18 (m, 1 H) ppm.
(2S,10R)-2-[Hydroxy(2-naphthyl)methyl]cyclohexan-1-one (13):[7,8a]
Yield 236.3 mg (0.93 mmol, 93%); anti/syn = 97:3, enantiomeric
excess: Ͼ99% (anti diastereomer) determined by HPLC (Daicel
Chiralpak OD-H column; iPrOH/hexane = 10:90; 1.0 mL/min,
20 °C, λ = 221 nm) tR = 15.7 min (anti, major) and tR = 22.2 min
(anti, minor). 1H NMR (300 MHz, CDCl3): δ = 7.70–7.90 (m, 4 H,
ArH), 7.40–7.55 (m, 3 H, ArH), 5.01 (d, J = 8.7 Hz, 1 H), 4.10 (s,
1 H), 2.71–2.78 (m, 1 H), 2.37–2.55 (m, 2 H), 2.09–2.14 (m, 1 H),
1.52–1.80 (m, 5 H), 1.28–1.42 (m, 2 H) ppm.
(2S,10R)-2-[Hydroxy(2-nitrophenyl)methyl]cyclopentan-1-one (18):[7]
Yield 230.5 mg (0.98 mmol, 98%); anti/syn = 55:45, enantiomeric
excess: 98% (anti diastereomer) determined by HPLC (Daicel Chi-
ralpak OD-H column; iPrOH/hexane = 5:95; 1.0 mL/min, 20 °C, λ
= 254 nm) tR = 39.8 min (anti, major) and tR = 43.2 min (anti,
minor). 1H NMR (300 MHz, CDCl3): δ = 8.00 (dd, J = 8.0, 0.8 Hz,
1 H, ArH), 7.89 (d, J = 8.0 Hz, 1 H, ArH), 7.66 (t, J = 8.0 Hz, 1
H, ArH), 7.44 (t, J = 8.0 Hz, 1 H, ArH), 5.21 (d, J = 7.2 Hz, 1 H),
2.90 (br., 1 H), 2.68 (d, J = 7.6 Hz, 1 H), 2.19–2.38 (m, 2 H),1.70–
2.03 (m, 4 H) ppm.
(2S,10R)-2-[Hydroxy(3-nitrophenyl)methyl]cyclopentan-1-one (19):[7]
Yield 232.9 mg (0.99 mmol, 99%); anti/syn = 75:25, enantiomeric
excess: 96% (anti diastereomer) determined by HPLC (Daicel Chi-
ralpak AD-H column; iPrOH/hexane = 8:92; 1.0 mL/min, 20 °C, λ
= 254 nm) tR = 29.4 min (anti, major) and tR = 43.3 min (anti,
minor). 1H NMR (300 MHz, CDCl3): δ = 8.17–8.18 (m, 1 H, ArH),
8.10 (ddd, J = 8.1, 2.3, 1.1 Hz, 1 H, ArH), 7.62–7.65 (m, 1 H,
ArH), 7.47 (t, J = 7.9 Hz, 1 H, ArH), 4.77 (d, J = 9.3 Hz, 1 H),
4.72 (s, 1 H), 2.16–2.47 (m, 3 H), 1.92–2.01 (m, 1 H), 1.61–1.78 (m,
2 H), 1.50–1.55 (m, 1 H) ppm.
(2S,10R)-2-[Hydroxy(4-chlorophenyl)methyl]cyclopentan-1-one
(20):[6e] Yield 206.7 mg (0.92 mmol, 92%); anti/syn = 61:39, enan-
(2S,10R)-2-[Hydroxy(1-naphthyl)methyl]cyclohexan-1-one (14):[7,8a] tiomeric excess: 95 % (anti diastereomer) determined by HPLC
Yield 228.9 mg (0.90 mmol, 90%); anti/syn = 98:2, enantiomeric
(Daicel Chiralpak AD-H column; iPrOH/hexane = 5:95; 1.0 mL/
Eur. J. Org. Chem. 2011, 1291–1299
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
1297